Table 4

Comparison of clinical scores according to ultrasound-defined remission and active disease at joints, entheses and tendons

 0140 (0–4)NSNSNSNSNS6.5 (1–17)NS
 ≥1561 (0–15)**10 (1–74)*
 0470 (0–10)2 (0–59)NSNS30 (0–80)NSNS6 (1–47)2 (0–20.3)
 ≥1233 (0–15.)**7 (0–33)**40 (0–80)*18 (5–74)***4.8 (0.6–49.5)*
 0651 (0–15)3 (0–59NS20 (0–80)NSNS0 (0–10)NSNS
 ≥155 (3–13)**13 (6–26)*30 (30–60)*2 (0–4)***
  • Data are shown as median and range in parenthesis.

  • Ptpain, EGA and PGA were measured on a Visual Analogue Ccale (range 0–100 mm) and are expressed in millimetres.

  • *p<0.05.

  • **p<0.01.

  • ***p<0.001.

  • –, not tested; CRP, C reactive protein (normal range 0–5 mg/L); EGA, evaluator's global assessment of disease activity; enthes., number of painful entheses according to Leeds, clinical MASEI or clinical MAEI+E scores; ESR, erythrocyte sedimentation rate (normal range 0–10 mm/first hour); HAQ, Health Assessment Questionnaire; dactylitis, dactylitis score; MASEI, Madrid Sonographic Enthesis Index; n, number of cases; NS, not significant; PD-dactylitis, ultrasound-defined dactylitis with PD-signals at involved joints and/or tendons; PD-j-score, power Doppler (PD)-score of joints; PD-MASEI-E, sum of entheses with PD-signals; enthesal sites were scanned according to Madrid Sonographic Enthesis Index plus lateral epicondyle; PD-perisyn, PD within peritendinous tissue; PD-teno, sum score of PD-signals related to tenosynovitis; PGA, patient's global assessment of disease activity; Ptpain, patient's pain assessment; SJ, swollen joint count; TJ, tender joint count.